ARS Pharmaceuticals, Inc. Common Stock SPRY

$5.62 -0.88% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-09-02 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-07-17 View →
8-K 8-K 2026-07-07 View →
4 Insider transaction 2026-07-02 View →
4 Insider transaction 2026-06-26 View →
4 4 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
4 Insider transaction 2026-06-26 View →
8-K 8-K 2026-06-25 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-12 View →
10-Q 10-Q 2026-05-15 View →
8-K 8-K 2026-05-15 View →
8-K 8-K 2026-05-13 View →
DEF 14A DEF 14A 2026-04-29 View →
10-K 10-K 2026-03-09 View →
8-K 8-K 2026-03-09 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2026-01-05 View →
4 Insider transaction 2025-11-14 View →
4 Insider transaction 2025-11-14 View →
4 Insider transaction 2025-11-14 View →
10-Q 10-Q 2025-11-10 View →
8-K 8-K 2025-11-10 View →
8-K 8-K 2025-09-29 View →
8-K 8-K 2025-08-28 View →
4 Insider transaction 2025-08-22 View →
4 Insider transaction 2025-08-22 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$5.62
Market Cap
$558.89 million
52-Week Range
$4.91 – $18.00
Average Volume
1.90 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.